Science and Research
HUMBOLDT: Efficacy and Safety of Filgotinib in Subjects with Active Non-Infectious Uveitis
This study is designed to demonstrate the efficacy and safety of filgotinib in subjects requiring high dose steroids for active non-infectious uveitis.
Overview
This is a randomised, masked, placebo-controlled Phase II trial in subjects with active non-infectious uveitis, despite at least two weeks of maintenance therapy with oral prednisolone.
The study is designed to demonstrate the efficacy and safety of filgotinib in subjects requiring high dose steroids for active non-infectious uveitis.
- Principal Investigator
Associate Professor Lyndell Lim
This is a randomised, masked, placebo-controlled Phase II trial in subjects with active non-infectious uveitis, despite at least two weeks of maintenance therapy with oral prednisolone.
The study is designed to demonstrate the efficacy and safety of filgotinib in subjects requiring high dose steroids for active non-infectious uveitis.
- Principal Investigator
Learn more
View this study at ClinicalTrials.gov
This international database listing provides more detailed information about this study.